Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.

< BACK TO ARCHIVE


2019 Nov


Pharmacotherapy


http://www.ncbi.nlm.nih.gov/pubmed/31514247?dopt=Abstract


39


11

Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.

Authors

Brexanolone for Postpartum Depression: Clinical Evidence and Practical Considerations.
Leader LD, O'Connell M, VandenBerg A
Pharmacotherapy. 2019 Nov; 39(11):1105-1112.
PMID: 31514247.

Abstract

To review the efficacy, safety, and pharmacology of brexanolone (Zulresso), a new antidepressant with a novel mechanism of action, in the treatment of postpartum depression (PPD).
Read This Paper